Topical bioavailability of diclofenac from locally-acting, dermatological formulations

被引:43
|
作者
Cordery, S. F. [1 ]
Pensado, A. [1 ]
Chiu, W. S. [1 ]
Shehab, M. Z. [1 ]
Bunge, A. L. [2 ]
Delgado-Charro, M. B. [1 ]
Guy, R. H. [1 ]
机构
[1] Univ Bath, Dept Pharm & Pharmacol, Bath, Avon, England
[2] Colorado Sch Mines, Chem & Biol Engn, Golden, CO 80401 USA
关键词
Diclofenac; Skin; Topical bioavailability; Topical bioequivalence; Dermato-pharmacokinetics; HUMAN STRATUM-CORNEUM; IN-VIVO; PERCUTANEOUS-ABSORPTION; DRUG PRODUCTS; BIOEQUIVALENCE; SKIN; VITRO;
D O I
10.1016/j.ijpharm.2017.06.063
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Assessment of the bioavailability of topically applied drugs designed to act within or beneath the skin is a challenging objective. A number of different, but potentially complementary, techniques are under evaluation. The objective of this work was to evaluate in vitro skin penetration and stratum corneum tape-stripping in vivo as tools with which to measure topical diclofenac bioavailability from three approved and commercialized products (two gels and one solution). Drug uptake into, and its subsequent clearance from, the stratum corneum of human volunteers was used to estimate the input rate of diclofenac into the viable skin layers. This flux was compared to that measured across excised porcine skin in conventional diffusion cells. Both techniques clearly demonstrated (a) the superiority in terms of drug delivery from the solution, and (b) that the two gels performed similarly. There was qualitative and, importantly, quantitative agreement between the in vitro and in vivo measurements of drug flux into and beyond the viable skin. Evidence is therefore presented to support an in vivo - n vitro correlation between methods to assess topical drug bioavailability. The potential value of the stratum corneum tapestripping technique to quantify drug delivery into (epi) dermal and subcutaneous tissue beneath the barrier is demonstrated. (C) 2017 Elsevier B.V. All rights reserved.
引用
收藏
页码:55 / 64
页数:10
相关论文
共 50 条
  • [41] PLASMA BIOAVAILABILITY OF 2 LONG-ACTING OXYTETRACYCLINE FORMULATIONS IN THE PIG
    ARCHIMBAULT, P
    NAVETAT, H
    VIDAL, R
    DOUIN, MJ
    MIGNOT, A
    VETERINARY RESEARCH, 1994, 25 (04) : 399 - 404
  • [42] New easy handling and sampling device for bioavailability screening of topical formulations
    Damien Salmon
    Elodie Gilbert
    Bruna Gioia
    Marek Haftek
    Christine Pivot
    Bernard Verrier
    Fabrice Pirot
    European Journal of Dermatology, 2015, 25 : 23 - 29
  • [43] Release kinetics of tretinoin from dermatological formulations
    Rebelo, ML
    Pina, ME
    DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1997, 23 (07) : 727 - 730
  • [44] Maximal Usage Trial: An Overview of the Design of Systemic Bioavailability Trial for Topical Dermatological Products
    Bashaw, Edward Dennis
    Tran, Doanh C.
    Shukla, Chinmay G.
    Liu, Xiaomei
    THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2015, 49 (01) : 108 - 115
  • [45] Maximal Usage Trial: An Overview of the Design of Systemic Bioavailability Trial for Topical Dermatological Products
    Edward Dennis Bashaw
    Doanh C. Tran
    Chinmay G. Shukla
    Xiaomei Liu
    Therapeutic Innovation & Regulatory Science, 2015, 49 : 108 - 115
  • [46] COMPARATIVE BIOAVAILABILITY OF 2 SUSPENSION FORMULATIONS OF POTASSIUM DICLOFENAC IN HEALTHY MALE-VOLUNTEERS
    MENDES, GBB
    FRANCO, LM
    MORENO, RA
    FERNANDES, AG
    MUSCARA, MN
    DENUCCI, G
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 1994, 32 (03) : 131 - 135
  • [47] BIOAVAILABILITY AND PHARMACOLOGIC ACTIVITY OF ORAL AND TOPICAL LONG-ACTING NITROGLYCERIN
    SMOLEN, VF
    ERB, RJ
    HANNEMAN, RE
    CLINICAL RESEARCH, 1979, 27 (02): : A546 - A546
  • [48] THE INFLUENCE OF A NEW HYDROCOLLOID DERMATOLOGICAL PATCH ON THE BLANCHING RESPONSE INDUCED BY TOPICAL CORTICOSTEROID FORMULATIONS
    MARTIN, GP
    MARRIOTT, C
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1989, 46 (05): : 828 - 836
  • [49] Integrating cytotopic strategy in transplantation: (1) Design of locally-acting coagulation inhibitors for use with anti-complement therapeutics
    Melchionna, T.
    Karegli, J.
    Farrar, C. A.
    McVey, J. H.
    Dorling, A.
    Sacks, S. H.
    Smith, R. A. G.
    MOLECULAR IMMUNOLOGY, 2010, 47 (13) : 2203 - 2203
  • [50] In vitro study of percutaneous absorption, cutaneous bioavailability and bioequivalence of zinc and copper from five topical formulations
    Pirot, F
    Miller, J
    Kalia, YN
    Humbert, P
    SKIN PHARMACOLOGY, 1996, 9 (04): : 259 - 269